Source: Investing.com ↗

Guggenheim raises Merck stock price target to $170 on cancer drug

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.02%

BTC/USDT

$85,912.00

-0.02%

ETH/USDT

$2,738.13

-0.17%

ZEC/USDT

$1,644.31

+9.30%

XRP/USDT

$1.59

+3.79%